Ditchcarbon
  • Contact
  1. Organizations
  2. Alembic Pharmaceuticals
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated a month ago

Alembic Pharmaceuticals

Company website

Alembic Pharmaceuticals Limited, commonly referred to as Alembic, is a prominent player in the global pharmaceutical industry, headquartered in Vadodara, India. Established in 1907, the company has a rich history marked by significant milestones, including its expansion into regulated markets and the development of a robust portfolio of generic and branded formulations. Alembic operates primarily in the areas of pharmaceuticals, biotechnology, and active pharmaceutical ingredients (APIs), focusing on therapeutic segments such as cardiovascular, anti-infective, and central nervous system disorders. The company is renowned for its commitment to quality and innovation, which is reflected in its extensive range of products that meet stringent international standards. With a strong market position, Alembic Pharmaceuticals has achieved notable success, including multiple approvals from regulatory authorities worldwide. Its dedication to research and development, coupled with a strategic approach to global expansion, solidifies its reputation as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Alembic Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

56

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Alembic Pharmaceuticals's score of 56 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Let us know if this data was useful to you

Alembic Pharmaceuticals's reported carbon emissions

In 2024, Alembic Pharmaceuticals, headquartered in India, reported significant carbon emissions, totalling approximately 70,977,700 kg CO2e for Scope 1 and about 67,544,140 kg CO2e for Scope 2. This reflects a commitment to transparency in their emissions reporting, although no Scope 3 emissions data was disclosed for this year. The company has set ambitious climate targets, aiming for a 63% reduction in absolute greenhouse gas emissions across all scopes by FY2034, using FY2022 as the baseline. Furthermore, Alembic Pharmaceuticals is committed to achieving net-zero emissions by FY2050, with a long-term goal of reducing emissions by 90% from the same baseline year. In 2023, the emissions data for India showed Scope 1 emissions at approximately 65,892,530 kg CO2e and Scope 2 at about 83,482,350 kg CO2e. This indicates a proactive approach to managing and reducing their carbon footprint over time. Alembic Pharmaceuticals' climate commitments align with industry standards, demonstrating a clear pathway towards sustainability and compliance with global climate goals. The company's initiatives are not cascaded from a parent organization, indicating an independent commitment to environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
79,194,000
00,000,000
Scope 2
83,482,000
00,000,000
Scope 3
644,996,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alembic Pharmaceuticals's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alembic Pharmaceuticals is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alembic Pharmaceuticals is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Alkem Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Hikma Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Sun Pharmaceutical Industries

IN
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Dr Reddys Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Torrent Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy